Sofradim was a European company focused in general surgery and uro-gynecolgy. They initially asked Global Medical to provide a full market research report on the targeted specialty and market opportunities and risks. This later expanded to an in-depth review and analysis of the US distribution options. Sofradim decided to create a US subsidiary with Global Medical acting as its management team. Global was responsible for all marketing, sales, financial and operations strategies, plans and organization. By identifying and building scientific, clinical and economic stories around key differentiating features, Global helped Sofradim become the fastest growing company in the market space within four years. Sofradim was acquired by a leading multi-national corporation for 5x sales.
